Glaxosmithkline reported GBP2.29B in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
AstraZeneca AZN:LN USD 3.09B 52M
Aurora Cannabis Inc ACB:CN CAD -63864000 556.28M
Canopy Growth Corp WEED:CN CAD -223691000 1.86B
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Johnson & Johnson JNJ:US USD 8.07B 98M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Supernus Pharmaceuticals SUPN:US USD -444000 11.77M
Takeda 4502:JP JPY 64.55B 90.92B
Teva Pharmaceutical TEVA:IT USD 768M 1.93B
Valeant Pharmaceuticals VRX:CN USD 329M 92M